The claim
A Rockefeller patent proves that 5G and mRNA vaccines can remotely control human cells.
Original review summary
The review says the patent describes experimental radiogenetics requiring genetically modified cells, while mRNA vaccines use lipid nanoparticles to deliver mRNA and have no capability to interact with 5G. It concludes that the social-media claim misinterprets the patent and that the technology is unrelated to COVID-19 vaccines.[S1]
Additional context
The review reports that Rockefeller scientists began radiogenetics research in 2011 and that a study was published in December 2014; it says the patent was filed on July 30, 2018, and granted in September 2020. [S1]
Research date:
Sources and attribution
- [S1] Fact Crescendo Sri Lanka original review
Original review · Retrieved October 15, 2026